Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

RBN-2397, a PARP7 Inhibitor, Synergizes with Paclitaxel to Inhibit Proliferation and Migration of Ovarian Cancer Cells

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.08.20.608802Source: DataRank Database

RBN-2397, a PARP7 Inhibitor, Synergizes with Paclitaxel to Inhibit Proliferation and Migration of Ovarian Cancer Cells is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: greenTopics (18)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Marwa W. Aljardali ORCID,Sridevi Challa ORCID,Sneh Koul,Jayanthi Lea ORCID,W. Lee Kraus ORCID

Live enrichment

PubMed:39229139 OpenAlex:https://openalex.org/W4401891759

National Institutes of Health

Grant: 2R01DK069710-04A1

The Role of PARP-1 in Hormone-Regulated Transcription

NIDDK NIH HHS

Grant: R01 DK069710

greenLicense: cc-by-nc-nd

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2024/08/21/2024.08.20.608802.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2024.08.20.608802

repositoryhttps://doi.org/10.1101/2024.08.20.608802

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39229139

Fields of Study

PARP inhibition in cancer therapyMetabolism, Diabetes, and CancerSirtuins and Resveratrol in Medicine

Keywords

PaclitaxelCancer researchOvarian cancerCancerOvaryCell biologyBiologyChemistryEndocrinologyGeneticsArticleMono ADP-ribosylation (MARylation)PARP7 (TiPARP)PARP7 inhibitor (RBN-2397)α-Tubulin stabilization

Sustainable Development Goals

SDG 0: Good health and well-being